Severe COVID-19 infection: An institutional review and literature overview

被引:0
|
作者
Akpoviroro, Ogheneyoma [1 ]
Sauers, Nathan Kyle [2 ]
Uwandu, Queeneth [1 ]
Castagne, Myriam [3 ]
Akpoviroro, Oghenetejiro Princess [4 ]
Humayun, Sara [1 ]
Mirza, Wasique [1 ]
Woodard, Jameson [1 ]
机构
[1] Geisinger Wyoming Valley Med Ctr, Dept Internal Med, Wilkes Barre, PA 18711 USA
[2] Penn State Univ, Dept Engn, State Coll, PA USA
[3] Boston Univ, Clin & Translat Sci Inst, Boston, MA USA
[4] Mater Dei Hosp, Dept Med, Msida, Malta
来源
PLOS ONE | 2024年 / 19卷 / 08期
关键词
ANGIOTENSIN-CONVERTING ENZYME; INVASIVE MECHANICAL VENTILATION; CONGESTIVE-HEART-FAILURE; OBSTRUCTIVE SLEEP-APNEA; CLINICAL CHARACTERISTICS; HOSPITALIZED-PATIENTS; SARS CORONAVIRUS; UNITED-STATES; LIVER-INJURY; AZITHROMYCIN;
D O I
10.1371/journal.pone.0304960
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background Our study aimed to describe the group of severe COVID-19 patients at an institutional level, and determine factors associated with different outcomes. Methods A retrospective chart review of patients admitted with severe acute hypoxic respiratory failure due to COVID-19 infection. Based on outcomes, we categorized 3 groups of severe COVID-19: (1) Favorable outcome: progressive care unit admission and discharge (2) Intermediate outcome: ICU care (3) Poor outcome: in-hospital mortality. Results Eighty-nine patients met our inclusion criteria; 42.7% were female. The average age was 59.7 (standard deviation (SD):13.7). Most of the population were Caucasian (95.5%) and non-Hispanic (91.0%). Age, sex, race, and ethnicity were similar between outcome groups. Medicare and Medicaid patients accounted for 62.9%. The average BMI was 33.5 (SD:8.2). Moderate comorbidity was observed, with an average Charlson Comorbidity index (CCI) of 3.8 (SD:2.6). There were no differences in the average CCI between groups(p = 0.291). Many patients (67.4%) had hypertension, diabetes (42.7%) and chronic lung disease (32.6%). A statistical difference was found when chronic lung disease was evaluated; p = 0.002. The prevalence of chronic lung disease was 19.6%, 27.8%, and 40% in the favorable, intermediate, and poor outcome groups, respectively. Smoking history was associated with poor outcomes (p = 0.04). Only 7.9% were fully vaccinated. Almost half (46.1%) were intubated and mechanically ventilated. Patients spent an average of 12.1 days ventilated (SD:8.5), with an average of 6.0 days from admission to ventilation (SD:5.1). The intermediate group had a shorter average interval from admission to ventilator (77.2 hours, SD:67.6), than the poor group (212.8 hours, SD:126.8); (p = 0.001). The presence of bacterial pneumonia was greatest in the intermediate group (72.2%), compared to the favorable group (17.4%), and the poor group (56%); this was significant (p<0.0001). In-hospital mortality was seen in 28.1%. Conclusion Most patients were male, obese, had moderate-level comorbidity, a history of tobacco abuse, and government-funded insurance. Nearly 50% required mechanical ventilation, and about 28% died during hospitalization. Bacterial pneumonia was most prevalent in intubated groups. Patients who were intubated with a good outcome were intubated earlier during their hospital course, with an average difference of 135.6 hours. A history of cigarette smoking and chronic lung disease were associated with poor outcomes.
引用
收藏
页数:34
相关论文
共 50 条
  • [1] Covid-19 and Fungal Infection: A literature review
    Darmadi, Darmadi
    Pakpahan, Cennikon
    Surja, Sem Samuel
    RAWAL MEDICAL JOURNAL, 2023, 48 (03): : 795 - 798
  • [2] An Overview of COVID-19 Infection
    Goldwire, Micheline A.
    US PHARMACIST, 2022, 47 (04) : 46 - 56
  • [3] Intravenous Immunoglobulin for Treatment of Severe Coronavirus Disease 19 (COVID-19) - A Literature Overview
    Rizvi, Syed
    Kreuwel, Huub
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2021, 147 (02) : AB67 - AB67
  • [4] Severe COVID-19 Infection during Pregnancy Requiring ECMO: Case Report and Review of the Literature
    Diago-Munoz, Diana
    Martinez-Varea, Alicia
    Perez-Sancho, Esther
    Diago-Almela, Vicente
    JOURNAL OF PERSONALIZED MEDICINE, 2023, 13 (02):
  • [5] Hand conditions as sequelae of infection with COVID-19: a literature review
    Koo, Kenneth Kin-Hoo
    Morris, James
    Ansari, Saif Akhter
    Younis, Fizan
    JOURNAL OF HAND SURGERY-EUROPEAN VOLUME, 2024, 49 (02) : 284 - 289
  • [6] The Interrelationship between HIV Infection and COVID-19: A Review of the Literature
    Wang, Yiyu
    Lai, Yu
    CURRENT HIV RESEARCH, 2024, 22 (01) : 6 - 15
  • [7] Literature Review of Hemadsorption Therapy in Severe COVID-19 Cases: a Narrative Review
    Koc, Suna
    Uysal, Harun
    CLINICAL LABORATORY, 2022, 68 (02) : 401 - 409
  • [8] Predictors for Severe COVID-19 Infection
    Bhargava, Ashish
    Fukushima, Elisa Akagi
    Levine, Miriam
    Zhao, Wei
    Tanveer, Farah
    Szpunar, Susanna M.
    Saravolatz, Louis
    CLINICAL INFECTIOUS DISEASES, 2020, 71 (08) : 1962 - 1968
  • [9] COVID-19: A New Severe Infection
    Kalil, Andre C.
    CURRENT OPINION IN CRITICAL CARE, 2021, 27 (05)
  • [10] ONSET OF STROKE IN PATIENTS WITH POST-COVID-19 SYNDROME FOLLOWING HOSPITALISATION FOR SEVERE COVID-19 INFECTION: A SYSTEMATIC LITERATURE REVIEW
    Fleming, C.
    Chakraborty, A.
    Jaiswal, T.
    Patel, P.
    Nair, S.
    VALUE IN HEALTH, 2022, 25 (01) : S121 - S121